[ Back to EurekAlert! ]

Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
440-670-6563
Dana-Farber Cancer Institute

Christopher Sweeney, Dana-Farber Cancer Institute (2 of 2)

Loading video...

Caption: Dr. Christopher Sweeney talks about his new study showing a drug combination extends survival by more than a year in metastatic prostate cancer.

Credit: Dana-Farber Cancer Institute

Usage Restrictions: None

Related news release: Drug combination extends survival by more than a year in metastatic prostate cancer


[ Back to EurekAlert! ]